These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34949183)

  • 1. Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions.
    Wang F; Chen T; Wang M; Chen H; Wang C; Liu P; Liu S; Luo J; Ma Q; Xu L
    BMC Urol; 2021 Dec; 21(1):183. PubMed ID: 34949183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
    Liu H; Ruan M; Wang H; Wang H; Li X; Song G
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
    Freifeld Y; Xi Y; Passoni N; Woldu S; Hornberger B; Goldberg K; Bagrodia A; Raj G; Margulis V; Cadeddu JA; Lotan Y; Francis F; Pedrosa I; G Roehrborn C; Costa DN
    Urol Oncol; 2019 Jan; 37(1):57-62. PubMed ID: 30446460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel sampling scheme with reduced cores in men with multiparametric MRI-visible lesions undergoing prostate biopsy.
    Ruan M; Wang H; Li X; Song G
    Abdom Radiol (NY); 2023 Jun; 48(6):2139-2147. PubMed ID: 37036488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
    Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
    Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis.
    Yu LP; Du YQ; Sun YR; Qin CP; Yang WB; Huang ZX; Xu T
    Asian J Androl; 2024 Sep; 26(5):479-483. PubMed ID: 38783630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China.
    Dai Z; Liu Y; Huangfu Z; Wang L; Liu Z
    Med Sci Monit; 2021 Aug; 27():e930234. PubMed ID: 34365459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.
    Krausewitz P; Fostitsch D; Weiten R; Kluemper N; Stein J; Luetkens J; Kristiansen G; Ellinger J; Ritter M
    World J Urol; 2023 Jan; 41(1):19-25. PubMed ID: 36477403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Regional Saturation Biopsy, Targeted Biopsy, and Systematic Biopsy in Patients with Prostate-specific Antigen Levels of 4-20 ng/ml: A Prospective, Single-center, Randomized Controlled Trial.
    Jiang X; Chen M; Tian J; Li X; Liu R; Wang Y; Zhao Y; Peng S; Niu Y; Xu Y
    Eur Urol Oncol; 2024 Aug; 7(4):944-953. PubMed ID: 38158249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.
    Borghesi M; Bianchi L; Barbaresi U; Vagnoni V; Corcioni B; Gaudiano C; Fiorentino M; Giunchi F; Chessa F; Garofalo M; Bertaccini A; Angelini S; Ercolino A; Casablanca C; Droghetti M; Golfieri R; Schiavina R
    Minerva Urol Nephrol; 2021 Jun; 73(3):357-366. PubMed ID: 33769008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal 3-Core Magnetic Resonance Imaging Ultrasound Fusion Targeted Plus Laterally 6-Core Systematic Biopsy in Prostate Cancer Diagnosis.
    Zhang C; Wu Q; Zhang Q; Zhang M; Cai D; Nie L; Chen X; Liu Z; Lin T; Xiao S; Yang L; Qiu S; Bao Y; Wei Q; Tu X
    Clin Genitourin Cancer; 2024 Aug; 22(4):102121. PubMed ID: 38834499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Role of Magnetic Resonance Imaging-Targeted Biopsy for Prostate Cancer in Biopsy-Naïve Men: A Meta-Analysis.
    Tu X; Liu Z; Zhang C; Chang T; Xu H; Bao Y; Li J; Jin K; Yuan Q; Qiu S; Yang L; Wei Q
    Urol Int; 2020; 104(3-4):187-198. PubMed ID: 31825927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort.
    Luzzago S; de Cobelli O; Mistretta FA; Piccinelli ML; Lorusso V; Morelli M; Bianchi R; Catellani M; Cozzi G; Di Trapani E; Pricolo P; Alessi S; Ferro M; Marvaso G; Matei DV; Jereczek-Fossa BA; Petralia G; Musi G
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):406-413. PubMed ID: 32989259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.
    Noujeim JP; Belahsen Y; Lefebvre Y; Lemort M; Deforche M; Sirtaine N; Martin R; Roumeguère T; Peltier A; Diamand R
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):575-580. PubMed ID: 36509930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
    Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
    Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy.
    Lee AYM; Chen K; Cheng CWS; Ho HSS; Yuen JSP; Ngo NT; Law YM; Tay KJ
    World J Urol; 2023 Aug; 41(8):2265-2271. PubMed ID: 37395756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: diagnostic yield of modified transrectal ultrasound-guided twelve-core combined biopsy (targeted plus systematic biopsies) using prebiopsy magnetic resonance imaging.
    Song C; Park SY
    Abdom Radiol (NY); 2021 Oct; 46(10):4974-4983. PubMed ID: 34181040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.